Publications


2017


Wenzel, J. M. & Cheer, J. F. (2017). Endocannabinoid regulation of reward and reinforcement through interaction with dopamine and endogenous opioid signaling. Neuropsychopharmacology.

 

Lopatina, N., Sadacca, B. F., McDannald, M. A., Styer, C. V., Cheer, J. F., & Schoenbaum, G. (2017). Ensembles in medial and lateral orbitofrontal cortex construct cognitive maps emphasizing different features of the behavioral landscape. Behavioral Neuroscience, 131(3), 201-212.

 

Covey, D. P., Mateo, Y., Sulzer, D., Cheer, J. F., & Lovinger, D. M. (2017). Endocannabinoid modulation of dopamine neurotransmission. Neuropsychopharmacology , 124, 52-61.

 

Patel, S., Hill, M. N., Cheer, J. F., Wotjak, C. T., & Holmes, A. (2017). The endocannabinoid system as a target for novel anxiolytic drugs. Neuroscience and BioBehavioral Reviews , 76(Pt A), 56-66.

 

Terrillion, C. E., Dao, D. T., Cachope, R., Lobo, M. K., Puche, A. C., Cheer, J. F., & Gould, T. D. (2017). Reduced levels of Cacna1c attenuate mesolimbic dopamine system function. Genes, Brain and Behavior , 16(5), 495-505.


2016


Can, A., Frost, D. O., Cache, R. Cheer, J. F., & Gould, T. D. (2016). Chronic lithium treatment rectifies maladaptive dopamine release in the nucleus accumbens. The Journal of Neurochemistry, 139(4), 576-585.

 

Zlebnik, N. E., & Cheer, J. F. (2016). Drug-Induced Alterations of Endocannabinoid-Mediated Plasticity in Brain Reward Regions. The Journal of Neuroscience, 36(40), 10230-10238.

 

Covey, D. P., Zlebnik, N. E., & Cheer, J. F. (2016). Endocannabinoid Regulation of Cocaine Reinforcement: an Upper or Downer? Neuropsychopharmacology , 41(9), 2189-2191.

 

Zlebnik, N. E., & Cheer, J. F. (2016). Beyond the CB1 receptor: Is cannabidiol the answer for disorders of motivation? Annual Review of Neuroscience.

 

Covey, D. P., Dantrassy, H. M., Zlebnik, N. E., Gildish, I., & Cheer, J. F. (2016). Compromised dopaminergic encoding of reward accompanying suppressed willingness to overcome high effort costs is a prominent prodromal characteristic of the Q175 mouse model of Huntington’s disease. The Journal of Neuroscience, 36(18), 4993-5002.

 

Can, A., Zanos, P., Moaddel, R., Kang, H. J., Dossou, K. S., Wainer, I. W., … & Gould, T. D. (2016). Effects of ketamine and ketamine metabolites on evoked striatal dopamine release, dopamine receptors, and monoamine transporters. Journal of Pharmacology and Experimental Therapeutics, 359(1), 159-170.

 

Lopatina, N., McDannald, M. A., Styer, C. V., Peterson, J. F., Sadacca, B. F., Cheer, J. F., & Schoenbaum, G. (2016). Medial orbitofrontal neurons preferentially signal cues predicting changes in reward during unblocking. The Journal of Neuroscience, 36(32), 8416-8424.

 

Covey, D. P., Bunner, K. D., Schuweiler, D. R., Cheer, J. F., & Garris, P. A. (2016). Amphetamine elevates nucleus accumbens dopamine via an action potential-dependent mechanism that is modulated by endocannabinoids. European Journal of Neuroscience.


2015


Lopatina, N., McDannald, M. A., Styer, C. V., Sadacca, B. F., Cheer, J. F., & Schoenbaum, G. (2015). Lateral orbitofrontal neurons acquire responses to upshifted, downshifted, or blocked cues during unblocking. eLife, 4, e11299.

 

Bagot, R. C., Parise, E. M., Peña, C. J., Zhang, H. X., Maze, I., Chaudhury, D., … & Deisseroth, K. (2015). Ventral hippocampal afferents to the nucleus accumbens regulate susceptibility to depression. Nature Communications, 6.

 

Hernandez, G., & Cheer, J. F. (2015). To act or not to act: endocannabinoid/dopamine interactions in decision-making. Frontiers in Behavioral Neuroscience, 9.

 

Covey, D. P., Wenzel, J. M., & Cheer, J. F. (2015). Cannabinoid modulation of drug reward and the implications of marijuana legalization. Brain Research, 1628, 233-243.

 

Wang, H., Treadway, T., Covey, D. P., Cheer, J. F., & Lupica, C. R. (2015). Cocaine-induced endocannabinoid mobilization in the ventral tegmental area. Cell Reports, 12(12), 1997-2008.


For more, visit JF Cheer at Pubmed or Google Scholar.